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Abstract
Isospora belli causes diarrhoea in patients with AIDS. Most respond to targeted therapy and recommendations are that
secondary prophylaxis can be stopped following immune reconstitution with ART. We report eight cases of chronic
isosporiasis that persisted despite standard antimicrobial therapy, secondary prophylaxis, and good immunological and
virological response to ART. Median CD4 nadir was 175.5 cells/mm3 and median highest CD4 while symptomatic was 373
cells/mm3. Overall 34% of stool samples and 63% of duodenal biopsy specimens were positive for oocytes. Four patients
died, two remain symptomatic and two recovered. Possible explanations for persistence of symptoms include host factors
such as antigen specific immune deficiency or generalised reduction in gut immunity. Parasite factors may include
accumulating resistance to co-trimoxazole. Research is required to determine the optimum dose and duration of co-
trimoxazole therapy and whether dual therapy may be necessary. Mortality was high and pending more data we
recommend extended treatment with high-dose co-trimoxazole in similar cases.
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Introduction
The coccidian parasite Isospora belli is among the most frequently
identified causes of chronic diarrhoea in patients with AIDS [1]. It
predominates amongst patients with CD4 count ,200 cells/mm3 [2]
and the incidence has decreased since the introduction of combination
antiretroviral therapy (ART) [3]. Treatment with co-trimoxazole is
effective in ART naive HIV-infected patients [4] although relapses are
common without secondary prophylaxis [5]. In cases of co-trimoxazole
intolerance, second line drug options include ciprofloxacin [6],
pyrimethamine [7] and nitazoxanide [8]. It is recommended that
secondary prophylaxis can be stopped when CD4 count is .200 cells/
mm3 for greater than 6 months on ART although this has not been
validated in clinical trials [9]. There are no reports of adult HIV-
infected patients who fail to eradicate Isospora belli following immune
reconstitution and chronic isosporiasis has only rarely been reported in
immunocompetent hosts [7]. The standard of care for Isospora belli in
South Africa is co-trimoxazole 960 mg 6 hourly for 10 days followed
by co-timoxazole 960 mg daily until CD4 count .200 cells/mm3. We
report 8 cases of recurrent, chronic isosporiasis in HIV-infected adults
on ART in whom HIV replication was suppressed to undetectable
levels and in whom immunological evidence of immune reconstitution
was demonstrated.
Methods
Local databases of patients referred to the infectious diseases
services at GF Jooste and Groote Schuur hospitals in Cape Town
were searched to identify patients with HIV infection and chronic
diarrhoea. Paper and electronic clinical records were then
examined to identify those with .1 stool or biopsy sample
positive for Isospora belli oocytes, persistent symptoms despite
appropriate targeted treatment and virological suppression and
immune reconstitution on ART.
Local research ethics committee approval was granted to
analyse data held on a departmental database. Information
reflecting the identity of the patients was removed.
Results
From January 2005 to January 2010 eight patients meeting the
search criteria were identified. Five were female and median age at
presentation was 34 years; their clinical course is summarised in
table 1 and a detailed history of 2 cases is described below.
Chronic isosporiasis was confirmed by the presence of oocytes on
multiple occasions in stool examined by modified acid-fast staining
or duodenal biopsy specimen examined by standard H&E
staining. In total 34% (23/67) of stool samples and 63% of (10/
16) duodenal biopsies were positive for oocytes. Alternative causes
of diarrhoea were excluded by multiple negative stool cultures for
Salmonella and Shigella species and negative Clostridium difficile toxin
testing. In addition 7 patients underwent duodenal biopsy, often
on multiple occasions, with no alternative cause for chronic
diarrhoea being identified. All patients achieved an undetectable
HIV viral load (,50 copies/ml) while remaining symptomatic.
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Four patients never had an HIV viral load .50 copies/ml despite
regular measurement. Three patients had only low level intermit-
tent viraemia (maximum 2780 copies/ml) and one experienced
high level virological failure (306671 copies/ml) but remained
symptomatic despite subsequently suppressing HIV viral load to
,50 copies/ml. Median CD4 nadir was 175.5 cells/mm3 and all
patients were symptomatic despite sustained improvement in CD4
count (median increase 227 cells/mm3). The highest CD4 count at
which a patient was symptomatic was 1013 cells/mm3 and the
median of the highest CD4 count at which patients were
symptomatic was 373 cells/mm3. Four patients died of complica-
tions of chronic diarrhoea and 2 remain symptomatic. Two
patients eventually recovered but had been symptomatic for 2
years despite adequate targeted treatment, virological suppression
and immune recovery.
Case 1
A 33 year old HIV-infected woman with a CD4 count of 32
cells/mm3 weighing 52 kg, presented with 3 months of watery
diarrhoea. No cause was found despite investigations including
multiple stool samples examined with modified acid-fast staining.
Stavudine, lamivudine and efavirenz were started 2 months later,
with efavirenz being switched to lopinavir/ritonavir following a
hepatitis B flare at 3 months. Despite ART, profuse watery
diarrhoea continued and after 4 months she was admitted to
hospital for rehydration, weighing 44 kg. Isospora belli oocytes were
observed in stool and treatment with co-trimoxazole at 1920 mg
b.i.d was successful. She gained weight to 48 kg although her
symptoms returned 3 months later, when oocytes were again
identified in stool, despite secondary prophylaxis with co-
trimoxazole 960 mg daily. At this time, her CD4 count had risen
to 174 cells/mm3 and HIV viral load was 1000 copies/ml. Repeat
episodes of severe diarrhoea with electrolyte disturbance continued
despite secondary prophylaxis; 1 year after starting ART she
weighed 38 kg. She required inpatient treatment for diarrhoea
and dehydration on 18 occasions over 4 years. Each time, she
improved on treatment, which included the use of single drug
therapy or combinations of oral or intravenous co-trimoxazole,
ciprofloxacin, albendazole and nitazoxanide. She relapsed on each
occasion, despite secondary prophylaxis with co-trimoxazole
960 mg b.i.d with or without ciprofloxacin 500 mg b.i.d. She
was supported with intravenous fluids, electrolyte supplementation
and required total parenteral nutrition on several occasions.
Diarrhoea was unlikely to be a side-effect of lopinavir/ritonavir as
she remained asymptomatic between acute episodes while
continuing this medication. Her CD4 was consistently .150
cells/mm3, peaking at 237 cells/mm3 after 20 months of ART.
HIV viral load was consistently ,50 copies/ml from 12 months of
ART. She died from complications of chronic diarrhoea 4 years
after starting treatment for isosporiasis.
Case 2
A 33 year old HIV-infected woman with a CD4 count of 210
cell/mm3 was treated with co-trimoxazole for microbiologically-
proven Isospora belli in stool and started on secondary prophylaxis.
Stavudine, lamivudine and nevirapine was started, but her gastro-
intestinal symptoms never completely settled despite secondary
prophylaxis with co-timoxazole at doses between 960 mg o.d. and
1920 mg b.i.d. CD4 count rose to 729 cells/mm3 and HIV viral
replication was suppressed after 6 months of ART. After 2 years of
intermittent symptoms, when her weight was 43 kg she was
referred for gastroscopy and Isospora belli was observed in duodenal
biopsy. She deteriorated and diarrhoea became more continuous;
over the following 30 months she was admitted to hospital with
increasing frequency. Isospora belli was observed in duodenal
biopsies on 2 further occasions, but was absent from multiple stool
samples taken at the same time. Co-trimoxazole, ciprofloxacin,
paromomycin, pyrimethamine and nitazoxanide were all tried for
relapses, with good initial response, but subsequent relapse on a
combination of high dose co-trimoxazole and ciprofloxacin
500 mg b.i.d. secondary prophylaxis. Her weight dropped to
32 kg and she required 6 admissions in a 4 month period. Her
clinical course was complicated by a deep vein thrombosis, major
depressive episode, and hypocalcaemia-induced tetany requiring
intubation and ICU admission. ART was continued throughout.
HIV viral load recordings were consistently ,50 copies/ml and
her CD4 count peaked at 1013 cells/mm3, 5 years after starting
ART. Five years after her first presentation, she died at home
having declined hospital admission for a further episode of severe
diarrhoea.
Discussion
To our knowledge, this case series represents the first
description of chronic, relapsing isosporiasis in HIV-infected
adults despite evidence of reconstitution of CD4 T-cell count and
suppression of HIV replication on ART. We think that Immune
Reconstitution Inflammatory Syndrome (IRIS) is an unlikely
explanation for our observations given the absence of a
disproportionate inflammatory reaction when initiating ART.
Our experience was of considerable morbidity necessitating
multiple hospital admissions and high mortality of up to 50%.
Depression was a common consequence.
There is no accepted gold standard method for diagnosing
isosporiasis and the sensitivity of diagnostic tests is therefore
unknown. However, we believe observing oocytes in stool or
duodenal biopsy has a specificity approaching 100%. Our
experience was of multiple negative stool examinations in patients
even during acute episodes and when duodenal biopsy was
positive; in total only 34% of stool samples were positive. This
suggests that stool microscopy is insensitive and of limited use in
excluding isosporiasis. Duodenal biopsies were more likely to be
positive in our patients, in total 63% were positive, but duodenal
biopsy is not routinely available in low resource settings where
most patients with HIV live. A molecular test for identifying
Isospora belli DNA in stool has been developed recently with
promising results although prospective studies on clinical speci-
mens are lacking [10].
Isosporiasis is typically associated with CD4 counts ,200
copies/mm3, but our observation was that whilst a low CD4 nadir
may be necessary for infection to become established, this case
series represents a sub-group of patients who failed to clear the
infection following reconstitution of T cell numbers. We hypoth-
esize that several factors may contribute to this phenomenon.
There may be a failure of recovery of the antigen-specific immune
response to Isospora belli alone, as despite recurrent clinical episodes
related to this specific infection, our patients did not manifest other
opportunistic infections which would indicate a broader functional
defect in T cell immunity. ART is known to lead to substantially
delayed, and only partial restoration of gastrointestinal CD4 T
cells [11] and therefore impaired gut immunity allowing persistent
infection or re-infection with Isospora belli is a possible mechanism.
Drug malabsorption is another possible factor although each
patient responded adequately to ART and initial oral therapy in
hospital suggesting otherwise. However, specific malabsorption of
co-trimoxazole cannot be ruled out. Poor compliance with
secondary prophylaxis was not judged to be a contributor, due
to pill count monitoring and adherence counselling. Therapeutic
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drug monitoring was not performed, hence anomalies in drug
pharmacokinetics cannot be ruled out.
Drug resistance to co-trimoxazole may have played a role in
relapse. Acute episodes of diarrhoea generally responded to
standard co-trimoxazole doses, arguing against resistance, al-
though intermediate susceptibility of strains in patients who
relapse may explain our observations. Unizoic cysts of Isospora belli
have been described in the lymphoid tissue of a patient with AIDS
[12] and lymph nodes may represent a site of chronic infection.
Parasite sequestration in immune privileged sites may also play a
role.
Prospective studies have shown the safety of discontinuing
secondary prophylaxis against Pneumocystis jirovecii and Cryptococcus
neoformans in patients with sustained improvements in CD4 counts
[13]. Similar studies of patients with Isospora belli infection are
lacking and our data suggest that similar guidelines may not be
safe, at least in a sub-group of patients who remain symptomatic.
The research priority in chronic isosporiasis is to determine the
optimal dose and duration of the co-trimoxazole, the most
efficacious drug. The efficacy of alternative treatments including
pyrimethamine and nitazoxanide must be determined and
combination therapy, possibly for extended periods, should be
assessed in non-responders. In similar patients we currently
recommend co-trimoxazole 1920 mg b.i.d. continued for up to 2
years while monitoring for myelotoxicity.
We have managed several similar cases of chronic diarrhoea in
HIV patients with immune restoration and virological suppression
in rural primary care facilities, who despite negative stool samples
(endoscopy and biopsy unavailable) have responded to empiric
treatment for Isospora belli. Chronic isosporiasis was likely in these
cases, so clinical diagnosis may be necessary in areas where
duodenal biopsy is not routinely available.
There are several limitations to our study. Detailed analysis of
strains from these patients was not undertaken, so we are unable to
differentiate between reactivation of clinical disease with the same
strain or re-infection with another strain. There are no accurate
data for the incidence of isospora diarrhoea in our setting so we
are unable to directly compare our patients with a group who were
successfully treated. However, a survey of laboratory reports over
2 K years at GF Jooste hospital found 36 individuals with at least
1 stool sample positive for isospora oocytes. Three of these are
included in our case series but the outcome of the others is
unknown (unpublished data). The ability to exclude all other
causes of diarrhoea was limited by resources. However multiple
stool cultures in all patients and small bowel biopsies in most
patients failed to reveal an alternative cause.
Conclusions
We have described a case series of chronic isosporiasis due
either to relapse or re-infection, in patients with good immuno-
logical and virological response to ART. Stool microscopy was
often negative and although duodenal biopsy seemed to perform
better, this investigation is rarely available outside of the major
tertiary hospitals in Africa. The mortality rate in our case series
was high, suggesting that new approaches to treatment such as
long term intravenous therapy need to be assessed in this sub-set of
patients.
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